• Skip to primary navigation
  • Skip to main content
  • Skip to footer

RAIRDA HomepageRAIRDA

The Rare Autoimmune Rheumatic Disease Alliance

  • About us
    • Our members
    • About RAIRDs
    • Our board
    • Our story
  • What we do
    • Our priorities
    • A quality standard for rare disease
    • Publications
  • News
  • Get involved
    • Personal stories
    • Share your story
    • Campaign for us
  • Contact us
  • Search

Online survey – Steroid PRO study

Are you being treated with steroids for your rheumatic condition? We need your help to test a new questionnaire about steroid impact on quality of life for people living in the UK, USA or Australia.  

UWE Bristol has launched a study looking  into the impact of rare rheumatic diseases on peoples’ health related quality of life. They have performed in-depth interviews with 60 patients in the UK, USA and Australia to identify the most important impacts of being treated with steroids and how that impacts on peoples’ quality of life. The interview data has been used to develop a questionnaire which should be useful for anyone treated with steroids for their rheumatic disease, e.g. vasculitis, lupus, scleroderma, Sjogren’s, myositis, polymyalgia rheumatica and giant cell arteritis.

The final Steroid PRO questionnaire will be used in clinics or clinical trials to measure the impact of steroids on peoples’ quality of life (and hopefully highlight the true benefits of novel treatments that reduce the need for steroids in the future). 

Here’s the direct link to the survey if you would like to read more or take part: https://bit.ly/3Hqy2GS

Share this post:

Share on Twitter Share on Facebook Share on LinkedIn Share on E-mail
More news
« Guidance on Covid-19 vaccination for the severely immunosuppressed
MELODY Study: An Overview »

Footer

  • Twitter

The @APPG_VGP is calling for evidence and responses from patients, hospitals, patient groups, charities, clinicians, academics and private companies, to look at the experience of the #Forgotten500k immunocompromised patients during the pandemic. appg-vulnerablegroups.org/new…

GIRFT has worked with RAIRDA to develop the pathways for Giant Cell Arteritis (GCA) and Connective Tissue Disease. All 4 pathways support clinicians to provide the best patient care, and allow patients and commissioners to see what they can expect from a service. twitter.com/NHSGIRFT/statu…

It's great to see RAIRDA's policy paper and the stories of people with RAIRDs receive coverage in Personnel Today, the Daily Express, the Daily Record and the Daily Mirror today. personneltoday.com/hr/call-to…

RAIRDA have produced a Q&A document to address misconceptions and common questions about COVID vaccinations for people with RAIRDs. rairda.org/vaccines-misco…

Despite visiting her GP on several occasions, it took Georgina over 18 months to reach a diagnosis. We urgently need a quicker and more effective diagnostic journey for people with RAIRDs.#RAIRDA #ResettingtheBalance rairda.org/resetting-the-…

Contact us